PPARG and bladder transitional cell carcinoma: In our work, RP11‐89 was evaluated through multiple assays and the results revealed that it could promote cell proliferation and invasive capacity while inhibits cell apoptosis in BLCA via miR‐27a‐3p/PPARγ.